title: [Updated guidelines 2012 for gastroesophageal reflux disease].
abstract: In 2010, a Korean guideline for the management of gastroesophageal reflux disease (GERD) was made by the Korean Society of Neurogastroenterology and Motility, in which the definition and diagnosis of GERD were not included. The aim of this guideline was to update the clinical approach to the diagnosis and management of GERD in adult patients. This guideline was developed by the adaptation process of the ADAPTE framework. Twelve guidelines were retrieved from initial queries through the Appraisal of Guidelines for Research & Evaluation II process. Twenty-seven statements were made as a draft and revised by modified Delphi method. Finally, 24 consensus statements for the definition (n=4), diagnosis (n=7) and management (n=13) of GERD were developed. Multidisciplinary experts participated in the development of the guideline, and the external review of the guideline was conducted at the finalization phase.
authors.affiliation: Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
authors.forename: Hye-Kyung
authors.initials: HK
authors.lastname: Jung
authors.forename: Su Jin
authors.initials: SJ
authors.lastname: Hong
authors.forename: Yun Ju
authors.initials: YJ
authors.lastname: Jo
authors.forename: Seong Woo
authors.initials: SW
authors.lastname: Jeon
authors.forename: Yu Kyung
authors.initials: YK
authors.lastname: Cho
authors.forename: Kwang Jae
authors.initials: KJ
authors.lastname: Lee
authors.forename: Joon Seong
authors.initials: JS
authors.lastname: Lee
authors.forename: Hyo Jin
authors.initials: HJ
authors.lastname: Park
authors.forename: Ein Soon
authors.initials: ES
authors.lastname: Shin
authors.forename: Sun Hee
authors.initials: SH
authors.lastname: Lee
authors.forename: Sang-Uk
authors.initials: SU
authors.lastname: Han
mesh_terms: D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000150:complications / Q000175:diagnosis; D016208:Databases, Factual; D004032:Diet; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D016145:Endoscopy, Digestive System; D050782:Esophageal pH Monitoring; D005764:Gastroesophageal Reflux / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D010437:Peptic Ulcer / Q000150:complications / Q000175:diagnosis; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000150:complications / Q000175:diagnosis
chemical_list: D000863:Antacids; D000897:Anti-Ulcer Agents; D000928:Antidepressive Agents; D006633:Histamine Antagonists; D054328:Proton Pump Inhibitors